Latest news: you should not queue in the blood of young people in the hope of staying younger. As far as we know, life does not work that way and the US Food and Drug Administration does not recommend it either.

The FDA has issued a warning against some organizations in the country that "offer plasma injections of young donors" to help treat diseases such as Alzheimer's disease, dementia, memory loss and normal aging. .

Yes, there are companies, including the controversial start-up Ambrosia Health, which warned the public before the FDA warning, offered these types of services.

And also charged thousands of dollars for this. Like $ 8,000 for a liter of plasma.

$ 8,000?!?!?!

One liter is about four cups. Do you know how many glasses of wine you can get for $ 8,000? And you will probably feel younger at the fourth glass.

"In simple terms, we are concerned that some patients may be targeted by unscrupulous actors extolling plasma treatments by young donors as remedies and remedies," reads the FDA warning. "Such treatments have no proven clinical benefit for the uses for which these clinics advertise them and are potentially harmful."

According to Forbes, the theory that a youngster's blood would rejuvenate you in turn is also the result of a Frankenstein experiment done on mice. The scientists paired the blood supply of an old mouse with a young mouse, which eventually made the old mouse "stronger, smarter and healthier, as well as their brighter fur".

Ambrosia Health has since ceased and its blood transfusion treatments are in compliance with the FDA warnings. Their website now reads as follows: "In accordance with the announcement made by the FDA on February 19, 2019, we have ceased treatments for patients."

The startup was founded by Jesse Karmazin, a former Stanford medical student, who said as a trainee at the National Institute of Aging have witnessed numerous blood transfusions.

"Some patients had some young blood and some old blood, and I was able to do statistics about it, and the results were really impressive," said Ambrosia Health's founder at Business Insider. "And I thought, that's the kind of therapy I would like to be available to me."

Karmazin is not allowed to practice medicine even though he has a degree in medicine.

Read or share this story: https://www.usatoday.com/story/life/2019/02/20/fda-issues-warning-young-blood-transfusions-ambrosia-health/2929640002/